Lindahl acts as an advisor when Amferia enters into an agreement with Orkla Wound Care
Through the collaboration with Orkla Wound Care, Amferia’s innovative technology will reach the veterinary market through Orkla’s leading brand Snögg Animal Care.
Amferia’s technology is based on an antimicrobial gel that inhibits bacterial growth and can help prevent infections – a priority area in the European veterinary market, particularly in view of the growing risk of antibiotic-resistant infections. Amferia’s technology and materials have been developed through many years’ research in collaboration with Chalmers University of Technology.
Read more about Amferia and the agreement at amferia.com.
Patrik Rindstål was the Lindahl partner in charge.
Do you want to know more? Contact:
Patrik Rindstål
Managing Partner Uppsala | AdvokatCarousel items
-
Knowledge
9/21/2026
Adaptive capacity – four capabilities for organisations in change
Anna Engqvist, Chief Compliance & Sustainability Officer at Lindahl, discusses adaptive capacity – how organisations, employees, tools and leadership must work together to meet change proactively. Read about the four capabilities.
-
Cases and transactions
9/14/2026
Lindahl has advised Pareto Securities AB on a rights issue
Lindahl acted as deal counsel to Pareto Securities AB in connection with a rights issue of shares in Teneo AI as part of the company’s refinancing.
-
News articles
9/4/2026
Mikael Wärnsby represents Sweden at international conference on new nuclear power
Mikael Wärnsby represented Sweden at EFELA’s international conference on licensing and regulatory frameworks for new nuclear power in Europe.
-
Portraits
7/3/2026
Jesper on business-oriented legal advice in energy: "It is not enough for the advice to be correct"
Lindahl's energy team is recognised in Legal 500 for combining deep regulatory expertise with broad commercial legal experience – find out how they support clients in a rapidly evolving sector.
-
Read more news and insights?
